baber/WOPTO huggingface dataset:
Patent JP-2995509-B2 (JP)
Inventor: AKETAGAWA KENICHI
IPC: H01L21/205
Filed: 1991-09-20
Granted: 1999-12-27
Abstract: A thin film deposition method consists of depositing a thin film on a wafer by supplying a reactant gas molecules toward and onto the wafer within a vacuum vessel or chamber. The pressure within the vacuum vessel is set to the pressure under which the mean free path (d) of the molecules contained in the supplied reactant gas can be longer than the shortest distance (L) between the wafer and the wall of the vacuum vessel exposed to the vacuum side, or d > L. The temperature of the wafer is set to the temperature (T sub) at which the reactant gas can cause substantially the thermally decomposing reaction. The temperature of the vacuum side-exposed wall of the vacuum vessel (T wall) is set to a temperature range having the lower limit higher than the temperature (T vap) at which the saturated vapor pressure can be maintained to be equal to the partial pressure of the molecules contained in the reactant gas, and having the upper limit lower than the temperature of the wafer (T sub), or T vap < T wall < T sub.
Patent JP-2991719-B2 (JP)
IPC: G02B3/08
Filed: 1988-11-10
Granted: 1999-12-20
Abstract: A diffractive multifocal optical element comprising a phase zone plate of a Cohen lens design containing rotationally symmetrical, curved repetitive patterns designed to operate at a specific wavelength and which are also curved in r<2> space.
Patent JP-2881586-B2 (JP)
IPC: A61K6/90
Filed: 1989-11-13
Granted: 1999-04-12
Abstract: A polyether-impression material comprising components (a) a polyether, which has at least two optionally substituted vinyl- and/or allyl-end groups, (b) an SiH component, (c) a platinum catalyst, and optionally (d) the usual additives characterized in that the SiH-component (b) can be obtained by the reaction of at least a bi- functional, or polyfunctional, e.g., trifunctional, allyl- or vinyl-hydrocarbon compound, the hydrocarbon radical of which, without taking account of the allyl- or vinyl-groups and the optionally present alkylene ether groups, has 6 to 30 C-atom and contains at least one aromatically unsaturated, heterocyclic, or cycloaliphatic ring, with at least one mole per vinyl- or allyl-group of at least a bifunctional, or polyfunctional, e.g., trifunctional, SiH compound of the formula:  <IMAGE>  or  <IMAGE>   in which e=0 to 8, g=0 to 8, h=0 to 4 and R4 and R10 are the same or different, and are each H, methyl or ethyl, with the proviso that at least 1 and at the most 5 of R4 to R10 are H, wherein g and h cannot simultaneously be O, and wherein at least the components (b) and (c) lie spatially separated from each other.
Patent JP-H0433874-B2 (JP)
IPC: C25D13/14
Filed: 1990-11-16
Abstract: The invention relates to a process and an apparatus for anodic or cathodic painting of hollow bodies, particularly cans such as drink cans or the like, using a water-soluble paint as electrolyte liquid. The latter is in contact with the cathode or anode and is fed in at least one uninterrupted jet, which produces a conducting connection, to the surfaces of the hollow body which form the anode or cathode. 
<??>In order to be able to coat hollow bodies in large numbers per unit time with such a process, the invention proposes that the hollow bodies (1) are pushed with the opening (3) down over an electrically conducting grid (4), the paint being flooded in or over the hollow bodies in jets rising up through the free spaces between the grid or grating rods from below and the entire inside and outside surface of the hollow bodies being covered with a continuous layer in the process. 
<IMAGE>
Patent JP-3577609-B2 (JP)
IPC: F16D23/06
Filed: 1994-12-26
Granted: 2004-10-13
Abstract: A baulkring-type synchronizer (18) includes cone clutch friction surfaces (24,48 and 26,50) and jaw clutch teeth (36b,28 and 36c,30) for frictionally synchronizing and positive connecting gears (14,16) to a shaft (12). A torque ring (63) is mounted in a shift sleeve (34) for limited rotation relative thereto and non-axial movement relative thereto. The ring defines self-energizing ramp surfaces (74a,74b,74c,74d), blocker surfaces (76a,76b,78a,78b), and reaction surfaces (76c,78c). The ring self-energizing ramp surfaces engage self-energizing ramp surfaces (70a,70b,72a,72b) defined on an outer circumference of a hub (32) affixed to the shaft. The ring blocker surfaces engage blocker surfaces (44a,44b,46a,46b) affixed to baulkrings (40,42). The ring reaction surfaces engage reaction surfaces (44c,44d,46c,46d) affixed to the baulkrings. Synchronizing torque produced by friction surfaces is partly reacted across the blocker surface, the remainder is reacted across the reaction surfaces, and the sum of the total synchronizing torque is reacted across the self-energizing ramp surfaces. A shift sleeve (34) is slidably splined to the hub (32) and is moved by an operator shift force (F<sub>o</sub>) and an additive force (F<sub>a</sub>) provided by the self-energizing ramp surfaces. Both forces (F<sub>o</sub> and F<sub>a</sub>) react against the blocker teeth to engage the friction surfaces.
Patent JP-3824647-B2 (JP)
IPC: D06M13/224
Filed: 1996-06-06
Granted: 2006-09-20
Abstract: PCT No. PCT/FR96/00851 Sec. 371 Date Mar. 25, 1997 Sec. 102(e) Date Mar. 25, 1997 PCT Filed Jun. 6, 1996 PCT Pub. No. WO96/41912 PCT Pub. Date Dec. 27, 1996Composite yarn comprising an intimate mixture of glass filaments and thermoplastic filaments, wherein said composite yarn is coated with an aqueous sizing composition containing at least one additive in the form of a fatty acid ester; and the aqueous sizing composition per se.
Patent JP-3180129-B2 (JP)
IPC: A61N1/32
Filed: 1990-12-19
Granted: 2001-06-25
Abstract: A method and apparatus are disclose for transdermal iontophoretic delivery of ionic species, such as a drug in ionic form, in which therapeutic, electrical pulses having controlled, distinctive, dual-segment waveform characteristics are applied which facilitate more efficient drug administration throughout each pulse. The therapeutic pulses are generated at a predetermined frequency and have a predetermined pulse width. A first pulse segment and a second pulse segment comprise each dual-segment, therapeutic pulse. The electrical attributes of each pulse segment, including amplitude and duration, are controlled to produce the desired, pulsed output waveform.
Patent JP-3463809-B2 (JP)
IPC: C25D15/02
Filed: 1992-02-20
Granted: 2003-11-05
Abstract: Bearings are described having overlay coatings. The overlay coating comprises a soft metallic matrix having incorporated therein from 0.05 to 2 wt% of a hard, non-metallic material, said material exhibiting a Vickers hardness (Hv) of from at least 300 to in excess of 600.
Patent JP-3102877-B2 (JP)
IPC: C12N1/11
Filed: 1990-03-14
Granted: 2000-10-23
Abstract: The present invention discloses a new neuronal nicotinic acetylcholine receptor subunit,  beta 4. The new subunit can form functional combinations with other neuronal nicotinic acetylcholine receptor subunits, including, but not limited to, alpha2, alpha3, alpha4 and beta2. A cDNA clone containing the DNA sequences that encode the novel receptor subunit of the invention has been deposited with the American Type Culture Collection for patent purposes.
Patent JP-3152435-B2 (JP)
IPC: A61M39/06
Filed: 1991-03-01
Granted: 2001-04-03
Abstract: An infusion port designed for the introduction of a catheter for fluid infusion or removal or other flexible filaments within a patient. The infusion port is buried subcutaneously and accessed using a needle which introduces the filament. The infusion port has means to prevent the introducing needle from being inserted past a certain point within the port whereas the introduced flexible element can be inserted beyond that point and is caused to be forced through an articulating valve. The valve of this disclosure features enhancements in its sealing ability and in some embodiments provides a differing level of frictional engagement with the filament upon insertion versus withdrawal. The infusion port of this invention also has design features which provide a relatively small distance between the surface of the skin and the position of the articulating catheter valve through which the introduced filament passes.
Patent JP-3431076-B2 (JP)
IPC: G02B21/06
Filed: 1993-09-08
Granted: 2003-07-28
Abstract: PCT No. PCT/DE93/00818 Sec. 371 Date Apr. 20, 1994 Sec. 102(e) Date Apr. 20, 1994 PCT Filed Sep. 8, 1993 PCT Pub. No. WO94/07170 PCT Pub. Date Mar. 31, 1994A bright-field transmitted-light lighting device for a microscope is described, for the homogeneous illumination of the lighting field diaphragm (LF) at large fields and small apertures and for the uniform illumination of the aperture diaphragm (AP) at small fields and large apertures, A raster plate (3) is disposed in the lighting beam path (7). The raster plate (3) is designed as a plane-parallel, transparent plate which exhibits a circular rastering at the center.
Patent JP-H07111436-B2 (JP)
IPC: B01L3/00
Filed: 1990-05-09
Abstract: A method is provided for carrying out an assay using a rotor assembly (220) comprising a rotor body (222) which is rotatable about an axis of rotation. The rotor body (222) has a central chamber (234) and six chambers (236 to 246) which are in communication with and radiate from the central chamber (234), and the rotor assembly (220) includes a shuttle (224) which is movable through said central chamber (234) into operative registry with any of said six chambers (236 to 246). The shuttle (224) comprises a reaction cup (252) carrying an immobilized antigen or an immobilized antibody for transport among said chambers. The method involves introducing an amount of whole blood into the first chamber (238), wash solution into the second chamber (240), an enzyme conjugate into the fourth chamber (240), an enzyme substrate solution into the fifth chamber and a reagent reference into the sixth chamber. The third chamber (236) is used for drying. The shuttle is moved between the chambers in a specified manner, the rotor body being rotated at various stages in the process, and a product is generated in the fifth chamber for comparison with the reagent reference in the sixth chamber.
Patent JP-3447732-B2 (JP)
IPC: C07D471/04
Filed: 1992-10-22
Granted: 2003-09-16
Abstract: 2-Ethyl 1H-imidazo[4,5-c]quinolin-4-amines, which are active as immunomodulators and antiviral agents, and intermediates in the preparation of such compounds, pharmaceutical compositions and pharmacological methods of use.
Patent JP-3589460-B2 (JP)
IPC: A61F13/20
Filed: 1993-11-15
Granted: 2004-11-17
Abstract: PCT No. PCT/SE93/00973 Sec. 371 Date Aug. 2, 1995 Sec. 102(e) Date Aug. 2, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/10955 PCT Pub. Date May 26, 1994A method for the manufacturing of an absorbent structure in an absorbent article, such as a sanitary napkin, tampon, panty protector, wound or sore dressing and like articles is produced by using absorbent material in roll form directly in the product without first defibrating the material and then forming a mat. The material possesses good dispersion properties and swelling properties, which are meaningful to the function of the product. A high surface dryness is obtained, among other things. In addition to cellulose fibers, the absorbent structure may also include superabsorbent material and/or binding fibers, among other ingredients. The pulp mat is very thin, therewith obviating the need to compress the mat further in the product. In the case of certain product applications, the material is softened mechanically prior to its use as an absorbent material.
Patent JP-3783143-B2 (JP)
IPC: A61K47/48
Filed: 1994-12-05
Granted: 2006-06-07
Abstract: PCT No. PCT/GB94/02658 Sec. 371 Date Jul. 2, 1996 Sec. 102(e) Date Jul. 2, 1996 PCT Filed Dec. 5, 1994 PCT Pub. No. WO95/15341 PCT Pub. Date Jun. 8, 1995The invention provides an antibody specific for carcinoembryonic antigen (CEA) which has a dissociation constant (Kd; of less than 5.0 nM for said antigen. The antibody is generally a single chain Fv (scFv) antibody. The antibody was initially obtained by screening a bacteriophage library for phage expressing high affinity CEA antibody. The antibody is useful for diagnosis and therapeutic treatment of colorectal tumors.
Patent JP-4169165-B2 (JP)
IPC: A23G9/06
Filed: 1996-10-10
Granted: 2008-10-22
Abstract: A process for the manufacture of a frozen spoonable water-ice comprising the steps of: (i) producing of ice flakes at a temperature of -10 DEG  C. or below, preferably -20 DEG  C. or below; (ii) grinding the ice flakes produced in step (i) into approximately spherical ice granules at a temperature of -10 DEG  C. or below, preferably -20 DEG  C. or below; (iii) mixing the ice granules produced in step (ii) with a flavoured ice slurry; and (iv) packaging the mixture obtained in step (iii) and freezing for storage.
Patent JP-3225046-B2 (JP)
IPC: C11C3/00
Filed: 1996-10-31
Granted: 2001-11-05
Abstract: An edible vegetable fat (I) free of trans-saturated fatty acid residue, comprises an interesterified mixture of: 30-90% high lauric rapeseed oil, and 10-70% oil A comprising 40% or more saturated fatty acid residues, 80% or more of which have 16-18C and 60% or less are 16C fatty acid residues. The fat preparation can be used to prepare a spread.
Patent JP-3608663-B2 (JP)
IPC: A61M16/14
Filed: 1995-03-30
Granted: 2005-01-12
Abstract: A system is provided for the delivery of a liquid anesthetic agent ti ab anesthetic vaporizer. The system includes a supply container having a spout defining an outlet through which the agent can be discharged. A reservoir is provided in the vaporizer for holding the agent, and a receiving station is provided on the vaporizer for receiving the container spout. The agent flows from the container through the spout by gravity into the reservoir. The container spout is located at the station to define the maximum liquid level of the agent in the vaporizer when gas flow into the container is blocked by the rising level of the liquid agent. In one embodiment, a frangible seal is provided in the container, an outlet valve is provided in the container, and an inlet valve is provided in the receiving station. The valves open automatically as the container is inserted into the receiving station of the vaporizer. Also, the container spout is preferably movable relative to a collar so as to automatically effect rupture of the frangible membrane as the container is inserted into the receiving station of the vaporizer.
Patent JP-3489839-B2 (JP)
IPC: E04G23/02
Filed: 1998-01-20
Granted: 2004-01-26
Abstract: Flat strip lamella for reinforcing weight-carrying or weight-transferring building components. It has a composite structure consisting of a plurality of pliant or loose-flex supporting fibers (26) aligned parallel to each other, and a binding matrix (28) which connects the supporting fibers to each other so that they are shear-resistant, and is fastenable by means of an adhesive (16) by its broad side to the surface of the building component (12) that is to be reinforced. So that the flat strip lamella, to which the binding matrix gives rigid elastic form, can also be bent over corner edges of a building component (12), the invention proposes that the binding matrix (28) be removed, in at least an intermediary area (30), by uncovering the supporting fibers (26), and that the uncovered supporting fibers be subjected to a liquid or pasty thermosetting plastic, in order to stabilize the bent-over condition.
Patent IE-S86145-B2 (IE)
Title: A method of monitoring radio signal coverage
Inventor: KENNY LIAM
IPC: H04B7/26
Filed: 2012-04-13
Abstract: The invention relates to a method of monitoring the radio signal strength at a specific location in a radio network having a radio node using a standard mobile handset. A special access point is provided in the network and the standard mobile handset is used to call the special access point. At least part of the communication link between the radio node and the standard mobile handset is monitored and both the uplink and the downlink measurements of the communication link are retrieved and used to generate a measurement report. A monitoring unit receives the measurement report, determines the signal strength from the monitoring report and thereafter transmits a signal strength indicator to the standard mobile handset. Preferably, the signal strength indicator comprises an audio signal.In this way, the operator of the standard mobile device is practically instantaneously provided with a clear unambiguous indicator of the signal strength allowing the operator easily identify areas of weak signal coverage in the location. Less skilled operatives can therefore monitor the radio signal coverage.
Patent AU-2001268527-B2 (AU)
Title: Device for biopsy and treatment of breast tumors
Inventor: ZINDEL LISA
IPC: A61B10/02
Filed: 2001-06-19
Granted: 2005-10-13
Abstract: A device for diagnosis and treatment of tumors and lesions within the body. A cannula adapted to apply suction through the lumen of the catheter to the tumor or lesion is described. The lumen has a self sealing valve through which a cryoprobe is inserted while the suction is being applied. The cryoprobe is then inserted into the lesion, and operated to ablate the lesion.
Patent AU-2002227015-B2 (AU)
Title: Processes and synthetic intermediates for preparing N-arylacridancarboxylic acid derivatives
Inventor: HANDLEY RICHARD S
IPC: C07D219/06
Filed: 2001-12-07
Granted: 2006-03-16
Abstract: Synthetic processes and intermediates are disclosed for the preparation of N-arylacridancarboxylic acid derivatives. The derivatives are esters, thioesters, amides and sulfonimides. A key feature of the processes is the preparation of N-aryl substituted intermediates by formation of a bond between the nitrogen atom of the acridan ring and a carbon atom of another aromatic or heteroaromatic ring compound. The arylation reaction is catalyzed by a palladium catalyst. The N-arylacridancarboxylic acid derivatives are useful in methods for producing light and in assays for peroxidase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs.
Patent AU-2002321278-B2 (AU)
Title: Transparent biaxially oriented polyolefin film with improved sealing qualities
Inventor: JUNG JOACHIM
IPC: C08J5/18
Filed: 2002-07-30
Granted: 2007-09-06
Abstract: The invention relates to the use of a pololyfin film for scaling purposes. The film consists of a base layer which is made of polyolefin polymers and at least one outer covering layer. The covering layer contains at least 50 wt. % of a polyolefin modified by maleic acid anhydride, in relation to the weight of the covering layer, and undergoes flame surface treatment on the surface of said covering layer.
Patent AU-2002359020-B2 (AU)
Title: Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
Inventor: KANG JIN-AH
IPC: A61K35/56
Filed: 2002-12-20
Granted: 2005-06-02
Abstract: A pharmaceutical composition for the prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation is provided. The composition contains purified sumsoo extract and purified ginseng extract containing saponin as the main component, without other herbal essential oil components.
Patent AU-2003244723-B2 (AU)
Title: Apparatus for screening and diagnosing by dual stethoscopic and Doppler detection
Inventor: BINDEFELD HERVE
IPC: A61B8/06
Filed: 2003-03-27
Granted: 2007-04-26
Abstract: The invention concerns an apparatus for early screening of cardiovascular diseases through dual stethoscopic and Doppler detection with means ensuring coherence between the two types of detection. According the invention, the medical screening and diagnosis apparatus comprises a sound transmitting linking conduit ( 3, 33 ) connected, on one end, to a housing ( 100 ) forming at least partly an ear trumpet ( 1 ') provided with a membrane ( 2 ), and, on the other end, at least an earphone ( 4 ) for listening to a stethoscopic signal from the ear trumpet ( 1 '). The invention is characterized in that the housing ( 100 ) of the apparatus contains at least an ultrasound probe ( 8 ) designed to enable convergence of reception of the ultrasonic and stethoscopic signals. The probe is connected to a transducer processing circuit ( 37 ) capable of supplying, from a Doppler signal, an audio signal by coupling the processing circuit to a loudspeaker ( 34 ) in contact with the ear trumpet for stethoscopic-type listening, and a video signal by coupling the processing circuit ( 37 ) to display means ( 39 ) to provide visual information.
Patent AU-2004213154-B2 (AU)
Title: Metallisied opaque film
Inventor: DETLEF HUTT
IPC: C08L23/08
Filed: 2004-02-20
Granted: 2009-11-19
Abstract: The invention relates to a metallised, coextruded, multi-layered, biaxially orientated polypropylene multi-layer film comprising a base layer containing vacuoles. Said base layer containing vacuoles is covered by one or several layers and the thickness of said covering layer or layers is, in total, at least 3 mum and the film on the outer surface of said covered layer or layers are metallised and the metallised film has a water vapour permeability of =0.5 g/m<SUP>2</SUP>*day at 38° C and 90 % relative air humidity and oxygen permeability of =50 cm<SUP>3</SUP>/m<SUP>2</SUP>*day*bar at 23° C. and 50% relative air humidity.
Patent AU-2004222439-B2 (AU)
Title: Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
Inventor: SAGAWA KATSUHIKO
IPC: A61K47/42
Filed: 2004-03-18
Granted: 2008-08-21
Abstract: Micellar preparation in which the solubility of a sparingly water-soluble anticancer agent has been heightened and which after intravenous administration, enables a high blood concentration to be maintained. The preparation has high medicinal activity and/or reduced side effects, and is formed from a block copolymer represented by formula (1): [wherein R1 represents hydrogen or C1-5 alkyl; R2 represents C1-5 alkylene; R3 represents methylene or ethylene; R4 represents hydrogen or C1-4 acyl; R5 represents hydroxyl, optionally substituted aryl C2-8 alkoxyl, substituted C1-4 alkylamino, or amino having a residue of either an amino acid or a peptide derivative; n is an integer of 5 to 1,000; m is an integer of 2 to 300; and x is an integer of 1 to 300; provided that the proportion of hydroxy in the R5's is 0 to 99% and x is not larger than m] and a sparingly water-soluble anticancer agent.
Patent AU-2004237571-B2 (AU)
Title: Filtering device incorporating nanoparticles
Inventor: BEPLATE DOUGLAS K
IPC: A61L2/00
Filed: 2004-03-12
Granted: 2008-04-17
Abstract: A filtering device incorporating nanoparticles (1) that are known to be capable of destroying bacteria, fungi, viruses, or toxins. The nanoparticles (1) are combined with a filter (2). The nanoparticles (1) may be pellets adjacent to the filter (2), a powder (12) of nanoparticles (1) coating at least one side of a filter (2), or impregnated into a filter (2). Optionally, two or more filters (2) are contained within an encasement (3) having an inlet (4) and an outlet (5). Preferably, at least one filter (2) has an electrical charge that is the same as the electrical charge of at least one target particle. Also preferably, coating is accomplished by having a filter (2) to be coated carry an electrical charge that is opposite to an electrical charge carried by the nanoparticles (1) in the powder (12). Optionally, a filter (2) can be either hydrophobic or hydrophilic.